Inventor · disambiguated record
Scott Eliasof
Also filed as: ELIASOF SCOTT · ELIASOF SCOTT D
5 granted patents·30 pending applications·26 citations·filing 1997–2019
78Inventor score
Files withELIASOF SCOTT15CERULEAN PHARMA INC9CRAWFORD THOMAS C3BAYER HEALTHCARE AG2UNIV OREGON HEALTH SCIENCES2
Top patents by PatentIndex Score
35 records- 0170US7169751B2Method of identifying a compound capable of treating a pain or a painful disorderBAYER HEALTHCARE AG·Filed 2004·Granted Jan 30, 2007·3 cites·7 claims
- 0269US2014286873A1Polymer-agent conjugates, particles, compositions, and related methods of useCRAWFORD THOMAS C·Filed 2013·Application pending·0 cites
- 0368US5882926AExcitatory amino acid transporter gene and usesUNIV OREGON HEALTH SCIENCES·Filed 1997·Granted Mar 16, 1999·14 cites·11 claims
- 0467US2014099263A1Polymer-agent conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2013·Application pending·0 cites
- 0565US2013011445A1Polymer-agent conjugates, particles, compositions, and related methods of useCRAWFORD THOMAS C·Filed 2012·Application pending·0 cites
- 0665US2012282306A1Polymer-agent conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2012·Application pending·0 cites
- 0764US7258971B2Methods and compositions for treating urological disorders using carboxypeptidase Z identified as 8263BAYER HEALTHCARE AG·Filed 2004·Granted Aug 21, 2007·4 cites·7 claims
- 0862US2011268658A1Polymer-agent conjugates, particles, compositions, and related methods of useCRAWFORD THOMAS C·Filed 2011·Application pending·0 cites
- 0962US2020046845A1Cyclodextrin-based polymers for therapeutic deliveryNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1061US2011189092A1Polymer-agent conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2010·Application pending·0 cites
- 1161US2014193510A1Polymer-Agent Conjugates, Particles, Compositions, and Related Methods of UseCERULEAN PHARMA INC·Filed 2014·Application pending·0 cites
- 1260US2010247668A1Polymer-agent conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2010·Application pending·0 cites
- 1358US2014072633A1Polymer-epothilone conjugates, particles, compositions and related methods of useELIASOF SCOTT·Filed 2013·Application pending·0 cites
- 1457US2015005230A1Cyclodextrin-based polymers for therapeutic deliveryELIASOF SCOTT·Filed 2014·Application pending·0 cites
- 1556US2013196906A1Cyclodextrin-based polymers for therapeutic deliveryCERULEAN PHARMA INC·Filed 2013·Application pending·0 cites
- 1656US2014296322A1Conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2014·Application pending·0 cites
- 1755US2014255374A1Compositions and methods for treatment of autoimmune and other diseaseELIASOF SCOTT·Filed 2013·Application pending·0 cites
- 1855US2017368194A1Cyclodextrin-based polymers for therapeutic deliveryCERULEAN PHARMA INC·Filed 2017·Application pending·0 cites
- 1954US2018193486A1Compositions and methods for treatment of autoimmune and other diseaseCERULEAN PHARMA INC·Filed 2017·Application pending·0 cites
- 2054US2013059816A1Compositions and methods for treatment of autoimmune and other diseaseCERULEAN PHARMA INC·Filed 2012·Application pending·0 cites
- 2152US2012302622A1Conjugates, particles, compositions, and related methodsELIASOF SCOTT·Filed 2012·Application pending·0 cites
- 2251US2010247669A1Polymer-agent conjugates, particles, compositions, and related methods of useCERULEAN PHARMA INC·Filed 2010·Application pending·0 cites
- 2351US2014105891A1Treatment of cancerCERULEAN PHARMA INC·Filed 2013·Application pending·0 cites
- 2450US2012064107A1Compositions and methods for treatment of autoimmune and other diseaseELIASOF SCOTT·Filed 2011·Application pending·0 cites
- 2550US2010285144A1Polymer-epothilone conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2010·Application pending·0 cites
- 2650US2012225129A1Conjugates, particles, compositions, and related methodsELIASOF SCOTT·Filed 2011·Application pending·0 cites
- 2748US2016058874A1Cyclodextrin-based polymers for therapeutic deliveryELIASOF SCOTT·Filed 2015·Application pending·0 cites
- 2846US2015209440A1Conjugates, particles, compositions, and related methods of useELIASOF SCOTT·Filed 2015·Application pending·0 cites
- 2942US6284505B1Excitatory amino acid transporter (EAAT) 5 protein from homo sapiensUNIV OREGON HEALTH & SCIENCE·Filed 1999·Granted Sep 4, 2001·3 cites·2 claims
- 3040US2013202659A1Polymer-agent conjugates, particles, compositions, and related methods of useCERULEAN PHARMA INC·Filed 2013·Application pending·0 cites
- 3140US2014037573A1Conjugates, particles, compositions, and related methodsCERULEAN PHARMA INC·Filed 2013·Application pending·0 cites
- 3238US5989825AExcitatory amino acid transporter gene and usesUNIV OREGON HEALTH SCIENCES·Filed 1998·Granted Nov 23, 1999·2 cites·11 claims
- 3338US2016101185A1Treatment of cancerGARMEY EDWARD G·Filed 2015·Application pending·0 cites
- 3437US2020093932A1Treatment of cancerBLUELINK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3533US2011300150A1Compositions and methods for treatment of autoimmune and other diseaseELIASOF SCOTT·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →